Stockreport

New subgroup analyses of CLEAR Outcomes data showed bempedoic acid reduced the risk of major adverse cardiovascular events across various patient groups [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF acid / ezetimibe fixed-dose combination) in Europe, presented at the 92 nd European Atherosclerosis Society Congress: In patients with obesity, bempedoic acid reduced [Read more]